EU’s von der Leyen: AstraZeneca has applied to EMA for its coronavirus vaccine authorization
|European Commission President Ursula von der Leyen tweeted out on Tuesday, AstraZeneca has applied to the European Medicines Agency (EMA) for its vaccine authorization in the EU.
Good news! @AstraZeneca has applied to @EMA_News to have its vaccine authorised in the EU. @EMA_News will assess the vaccine’s safety & efficacy.
— Ursula von der Leyen (@vonderleyen) January 12, 2021
Once the vaccine receives a positive scientific opinion, we will work full speed to authorise its use in Europe.
Meanwhile, senior EU health official Sandra Gallina said that the AstraZeneca vaccine may gain approval at the end of the month while speaking before lawmakers in the parliament.
Market reaction
EUR/USD holds gains around 1.2160, adding 0.09% on the day, as of writing.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.